We are delighted to announce that the executive summary of the CDDF & EORTC joint workshop on “Health Technology Assessment in Cancer Drug Development” has been published today.
This multi-stakeholder workshop was held on 5-6 October 2026 in Brussels (BE) to help stakeholders navigate the rapidly evolving HTA landscape in Europe and understand what it means for cancer care.
📝 To learn more about our discussions, read the executive summary and feel free to share your thoughts with us: https://cddf.org/?dm_download=1&file=/wp-content/uploads/2026/10/CDDF-Oct-Workshop-2026_Executive-Summary.pdf